Noticias de TEVA_US
Noticias del mercado
Últimas noticias sobre TEVA_US — 466 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Teva Pharmaceutical Industries stock began trading ordinary shares directly on the NYSE on September
Fund plans to sell 367,600 Teva shares worth $14.4M under Rule 144, out of about 1.17B ordinary shares outstanding.
Teva Pharmaceutical Industries stock is trading around USD 38.92 as of September 17, 2026, close to
Teva Pharmaceutical Industries (NYSE:TEVA) began direct trading of its ordinary shares on the New York Stock Exchange, replacing its prior American Depositary Shares program. The move reshapes Teva's U.S. capital markets presence by aligning its primary share class with global investors on a single major venue. Management has linked the NYSE ordinary share listing to the firm's Pivot to Growth plan, which includes new product launches and the use of AI to improve efficiency. Teva's shift to...
California State Teachers Retirement System boosted its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 3,376.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,
Página 8 de 24